EVOLVE Trial - EndoVascular Treatment Of Wide-Neck Aneurysms
B
Bradley N. Bohnstedt, MD
Primary Investigator
Overview
The purpose of this study is to collect data on the use of the Surpass Evolve Flow Diverter to determine its safety and efficacy.
Description
Participants will complete blood clot testing; brain imaging at the time of the procedure and again at 6, 12, and 36-months post-procedure; blood tests; neurological and cranial nerve exams; assessments. Participants will also return to their doctor at 1 month, 6 months, 12 months, 24 months, and 36 months after treatment with the Surpass Evolve Flow Diverter implant.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Wide-Neck Aneurysm
-
Age: Between 18 Years - 80 Years
-
Gender: All
Individuals between 18 and 80 years of age with a single unruptured intracranial aneurysm with multiple increased risk factors for rupture.
Individuals with certain other serious concurrent medical conditions will not be eligible.
Women who are pregnant will not be eligible.
Updated on
30 Apr 2024.
Study ID: 2002543601
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
